What is BioMarin (BMRN)?
BioMarin Pharmaceutical Inc. is a biotechnology company specializing in the development and commercialization of therapies for rare genetic diseases and serious medical conditions. The company focuses on innovative treatments that address unmet medical needs, often targeting small patient populations. BioMarin's product portfolio includes enzyme replacement therapies, gene therapies, and other biologics. It invests heavily in research and development to advance novel therapeutic approaches, including genetic medicine. The company collaborates with academic institutions, regulatory agencies, and other stakeholders to bring treatments to market. BioMarin operates globally, providing access to its therapies through various healthcare systems. Its mission centers on improving the quality of life for patients with rare disorders.
BioMarin Stock Price Today: Live Overview
The price today is shaped by the live market flow, with BioMarin priced at $54.40. The intraday fluctuation ranges from $53.36 to $55.4, accompanied by a daily change of -1.7082%.
FAQ: BioMarin (BMRN)
What is the current price of BMRN stock?
BioMarin's current price is $54.40.
Does BMRN pay dividends?
BioMarin pays dividends to its shareholders.
Does BMRN have a formal corporate presence or regional headquarters in the UAE?
BioMarin operates in the UAE through partners and distributors without an official regional office.
What is BMRN best known for?
BioMarin is most famous for developing therapies for rare genetic diseases.
What assets are typically shown together with BMRN?
Commonly shown alongside BMRN: Emergent BioSolutions, Harmony Biosciences Holdings, Inc., Jazz Pharma
Latest shares articles



